Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions

Biochemical and Biophysical Research Communications

Volumn 434, Issue 1, 2013, Pages 166-172

  Mandl, Markus ^a   Kapeller, Barbara ^a   Lieber, Roman ^a   Macfelda, Karin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Angiogenesis; ARNT; HIF; Hypoxia; Invasion; Melanoma

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA;

ANGIOGENESIS; ARTICLE; CELL HYPOXIA; CELL INVASION; CHORIOALLANTOIS; DIMERIZATION; GENE OVEREXPRESSION; HEN EGG TEST CHORIOALLANTOIC MEMBRANE ASSAY; HUMAN; HUMAN CELL; IMMUNOASSAY; MEDIATOR; MELANOMA CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; TUMOR CELL LINE;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; CELL LINE, TUMOR; CHICK EMBRYO; COBALT; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELANOMA; UP-REGULATION;

EID: 84876796112     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.051     Document Type: Article

References (25)

1. Dayan F., Mazure N.M., Brahimi-Horn M.C., Pouyssegur J. A dialogue between the hypoxia-inducible factor and the tumor microenvironment. Cancer Microenviron. 2008, 1:53-68.
2. Rankin E.B., Giaccia A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 2008, 15:678-685.
3. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148:399-408.
4. Kuphal S., Winklmeier A., Warnecke C., Bosserhoff A.K. Constitutive HIF-1 activity in malignant melanoma. Eur. J. Cancer 2010, 46:1159-1169.
5. Gray-Schopfer V., Wellbrock C., Marais R. Melanoma biology and new targeted therapy. Nature 2007, 445:851-857.
6. Sekulic A., Haluska P., Miller A.J., Genebriera De Lamo J., Ejadi S., Pulido J.S., Salomao D.R., Thorland E.C., Vile R.G., Swanson D.L., Pockaj B.A., Laman S.D., Pittelkow M.R., Markovic S.N. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin. Proc. 2008, 83:825-846.
7. Milani M., Harris A.L. Targeting tumour hypoxia in breast cancer. Eur. J. Cancer 2008, 44:2766-2773.
8. Wilson W.R., Hay M.P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11:393-410.
9. Semenza G.L. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 2004, 19:176-182.
10. Zagorska A., Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 2004, 51:563-585.
11. Karar J., Maity A. PI3K/AKT/mTOR pathway in angiogenesis. Front. Mol. Neurosci. 2011, 4:51.
12. Semenza G.L. Oxygen homeostasis. Wiley Interdiscip. Rev. Syst. Biol. Med. 2010, 2:336-361.
13. Pore N., Jiang Z., Shu H.K., Bernhard E., Kao G.D., Maity A. Akt1 activation can augment hypoxia-inducible factor-1alpha expression by increasing protein translation through a mammalian target of rapamycin-independent pathway. Mol. Cancer Res. 2006, 4:471-479.
14. Chen J., Zhao S., Nakada K., Kuge Y., Tamaki N., Okada F., Wang J., Shindo M., Higashino F., Takeda K., Asaka M., Katoh H., Sugiyama T., Hosokawa M., Kobayashi M. Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am. J. Pathol. 2003, 162:1283-1291.
15. Higashimura Y., Yamaji R., Harada N., Nakao M., Nakano Y., Inui H. Construction of a dominant negative form of human hypoxia-inducible factor-2alpha. Biosci. Biotechnol. Biochem. 2010, 74:2100-2102.
16. Park E.J., Kong D., Fisher R., Cardellina J., Shoemaker R.H., Melillo G. Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1. Cell Cycle 2006, 5:1847-1853.
17. Uchida T., Rossignol F., Matthay M.A., Mounier R., Couette S., Clottes E., Clerici C. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J. Biol. Chem. 2004, 279:14871-14878.
18. Chilov D., Camenisch G., Kvietikova I., Ziegler U., Gassmann M., Wenger R.H. Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J. Cell Sci. 1999, 112(Pt 8):1203-1212.
19. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. USA 1995, 92:5510-5514.
20. Falkner E., Eder C., Kapeller B., Froschl W., Schmatz C., Macfelda K., Losert U.M. The mandatory CAM testing of cells and scaffolds for tissue engineering: benefits for the three Rs of cooperation with the vaccine industry. Altern. Lab. Anim. 2004, 32:573-580.
21. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
22. Liu L.Z., Li C., Chen Q., Jing Y., Carpenter R., Jiang Y., Kung H.F., Lai L., Jiang B.H. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One 2011, 6:e19139.
23. Skinner H.D., Zheng J.Z., Fang J., Agani F., Jiang B.H. Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J. Biol. Chem. 2004, 279:45643-45651.
24. Licht A.H., Muller-Holtkamp F., Flamme I., Breier G. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 2006, 107:584-590.
25. Huang L.E., Arany Z., Livingston D.M., Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 1996, 271:32253-32259.